Streetbeat News

Products Services

WMT

Reuters reported that Walmart is considering a $200 million investment in self-driving forklifts.

Portfolio Pulse from charles@benzinga.com

July 26, 2024 | 11:15 am

SYTA

VZ

Verizon has partnered with Siyata Mobile to launch the Siyata SD7, a push-to-talk device aimed at improving communication for first responders and enterprise clients in the U.S.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 11:10 am

CHTR

Charter Communications reported a decrease of 149,000 residential and SMB Internet customers in Q2, while residential and SMB mobile lines increased by 557,000. As of June 30, 2024, Charter served 30.4 million Internet customers and 8.8 million mobile lines.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 11:09 am

BCS

HA

Barclays US Consumer Bank has renewed its co-branded credit card program with Hawaiian Airlines. Barclays will continue to issue the Hawaiian Airlines World Elite Mastercard for consumers and the Hawaiian Airlines World Elite Business Mastercard for small businesses.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 11:04 am

SDGR

Schrodinger has announced a new initiative to expand the use of computational tools for predictive toxicology, funded by a $10 million grant from the Bill & Melinda Gates Foundation.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 11:04 am

ODV

Osisko Development announced the lifting of the fire evacuation order near its Cariboo Gold Project by the BC Wildfire Service. The mine site infrastructure was unaffected, and all project activities will resume. The company will continue to monitor the wildfire situation to ensure employee safety.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 11:03 am

MRK

The European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending the approval of Merck's Keytruda in combination with Padcev (Enfortumab Vedotin) for the first-line treatment of unresectable or metastatic conditions.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 10:54 am

AZN

The FDA's Oncologic Drugs Advisory Committee acknowledged that AstraZeneca's Imfinzi (Durvalumab) met the primary endpoint of event-free survival for resectable non-small cell lung cancer (NSCLC) in the AEGEAN Phase 3 trial. The trial showed a tolerable safety profile for patients treated with Imfinzi in combination with neoadjuvant chemotherapy before surgery and as adjuvant monotherapy after surgery.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 10:52 am

BA

TSLA

The return of astronauts aboard Boeing's Starliner spacecraft remains uncertain due to technical issues, with NASA considering using SpaceX's Dragon spacecraft as a backup. The Starliner has faced multiple delays since its inception, and its success is crucial for Boeing to join SpaceX in shuttling astronauts to and from the ISS.

Portfolio Pulse from Anan Ashraf

July 26, 2024 | 10:18 am

PODD

Insulet Corporation has raised its full-year 2024 revenue outlook for its Omnipod product line to 18%-21%, up from the previous 15%-19%.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 10:03 am